Guest Blogs - Page 5 of 47 - Express Pharma

U.S. Tariffs on India’s pharma: Who pays, what’s at risk

Can we reduce plastics usage in pharmaceutical industry? – Think

U.S. trade policy is jeopardising the U.S. – India pharma supply chain

Why India’s B.Pharm graduates need a standardised National Exit Exam

Enhancing visibility, predictability and transparency in IP procedures

Rethinking trust: what pharma can learn from Indian corner shops

Beauty, boosters and the law: Who’s watching India’s wellness market?

Hyderabad: Accelerating the future of life sciences

Why most extractables & leachables studies fail regulatory review-and how to fix them

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3